Aller au contenu principal
Accès ouvert déclaré 2024 preprint

PYK2 in the dorsal striatum of Huntington’s disease R6/2 mouse model

0Citations signalées, ce qui n’est pas une note de qualité
15Institutions déclarées
3Pays d’affiliation déclarés

Rattachement africain : fr, es, us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Huntington’s disease (HD) is a devastating disease due to autosomal dominant mutation in the HTT gene. Its pathophysiology involves multiple molecular alterations including transcriptional defects. We previously showed that in HD patients and mouse model, the protein levels of the non-receptor tyrosine kinase PYK2 were decreased in the hippocampus and that viral expression of PYK2 improved the hippocampal phenotype. Here, we investigated the possible contribution of PYK2 in the striatum, a major brain region altered in HD. PYK2 mRNA levels were decreased in the striatum and hippocampus of R6/2 mice, a severe HD model. PYK2 protein levels were also decreased in the dorsal striatum of R6/2 mice and in the putamen of human patients. PYK2 knockout by itself did not result in motor symptoms observed in HD mouse models. Yet, we examined whether PYK2 deficiency participated in the R6/2 mice phenotype by expressing PYK2 in the dorsal striatum using AAV vectors. With an AAV1/ Camk2a promoter, we did not observe significant improvement of body weight, clasping, motor activity and coordination (rotarod) alterations observed in R6/2 mice. With an AAV9/ SYN1 promoter we found an improvement of body weight loss and a tendency to better rotarod performance. DARPP-32 immunofluorescence was increased following AAV9/ SYN1 -PYK2 injection compared to AAV9/ SYN1 -GFP, suggesting a possible partial beneficial effect on striatal projection neurons. We conclude that PYK2 mRNA and protein levels are decreased in the striatum as in hippocampus of HD patients and mouse models. However, in contrast to hippocampus, striatal viral expression of PYK2 has only a slight effect on the R6/2 model striatal motor phenotype. Highlights Huntington’s disease is a lethal genetic disease altering striatum, cortex, and hippocampus Restoring PYK2 levels in hippocampus improved hippocampal phenotype of a Huntington mouse model We show that PYK2 levels are decreased in the striatum of R6/2 mice and human patients Viral expression of PYK2 in the striatum has only a small effect on R6/2 mouse model motor phenotype but improves weight loss

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
PYK2 in the dorsal striatum of Huntington’s disease R6/2 mouse model
Date Crossref
20/01/2024
Éditeur
openRxiv
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Genetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatments

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.